Filser, M.
Schreiber, H.
Pöttgen, J.
Ullrich, S.
Lang, M.
Penner, I. K.
Article History
Received: 7 May 2018
Revised: 21 August 2018
Accepted: 22 August 2018
First Online: 31 August 2018
Compliance with ethical standards
:
: The study was performed in accordance with the Declaration of Helsinki. It was approved in October 2014 by the ethical committee of the University of Hamburg, committee’s reference number is PV4770, and in June 2014 by the Landesärztekammer (LÄK) Baden-Württemberg, Stuttgart, committee’s reference number is F-2014-048. All participants were informed of the full details of the study and to give their confirmation to participate.
: Not applicable. There are no details, images, or videos relating to an individual person included in this manuscript.
: The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.
: MF has nothing to disclose. HS has received travel Grants and honoraria for speaking at scientific meetings, participating in scientific advisory boards and consulting activities from Almirall, Bayer Healthcare, Biogen GmbH, Genzyme, Merck, Novartis and Teva. JP has received travel cost compensation from Bayer Pharma and honoria for speaking at scientific meetings from Novartis Pharma GmbH. SU has nothing to disclose. ML has received travel Grants, speaker’s honoraria, financial research support, consultancy fees from Teva, Merck Serono, Genzyme -Sanofi, Novartis, Bayer, Biogen. IKP has received honoraria for speaking at scientific meetings, serving at scientific advisory boards and consulting activities from Adamas Pharma, Almiral, Bayer Pharma, Biogen GmbH, Desitin, Genzyme, Merck Serono, Novartis Pharma GmbH, Roche and Teva.